Quality Assessment of New Liquid Biopsy Techniques

Quality Assessment of New Liquid Biopsy Techniques - EQA of liquid biopsy techniques

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON49338

Enrollment

Registered

2021-01-21

Start date

2020-12-01

Completion date

Unknown

Last updated

2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer neoplasm

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Metastatic cancer 2. Fit enough to deliver a maximum of 120 mL of peripheral blood, assessed by treating physician 3. Written informed consent

Exclusion criteria

Exclusion criteria: None specified

Design outcomes

Primary

Measure	Time frame
The primary endpoint of this study is to assess quality parameters (intra- and interlaboratory variation, time-to-processing influence, transport influence) of emerging liquid biopsy techniques.	—

Countries

Netherlands

Outcome results